New data regarding Ganymed Pharmaceuticals' drug IMAB362, presented at...
During his recent visit to the National Institute of Animal Nutrition ...
Research published today is poised to deliver never-before-seen breakt...
Dr Nathwani will be responsible for enterprise-wide medical, patient s...
Pharma Major Lupin announced that its US subsidiary, Gavis Pharmaceuti...
As explored in an abstract presented at the 2016 American Society of C...
With the cost of bringing a single novel drug to market estimated to b...
Biocon and Quark Pharmaceuticals,a leader in the discovery and develop...
Thalassemia is a disorder of abnormal formation of hemoglobin and ther...
According to a new market research report published by MarketsandMarke...
The resulting merger will generate revenues close to $406 million and ...
ChemoCentryx's CCX168, an orally administered small molecule in develo...
More than 20 tumor types are being treated with one or more of the 70 ...
Horizon Pharma and Hyperion Therapeutics have announced that they have...
New Page 1 Biotech's New Wave of Entrepreneurs A YEAR L...
The event is being organized to showcase the ongoing teaching and rese...
The National Biotechnology Development Strategy 2015-20 was unveiled o...
Come July 3rd, Chennai will witness a large gathering of delegates rep...
